ClinicalTrials.gg
Sign In

Placenta Previa clinical trials

The registry lists 80 studies for Placenta Previa across more than 10 countries. 17 are recruiting or about to start. 56 of them are mainly about Placenta Previa (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-22.

Get an email when these change. Save the Placenta Previa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
35
Status unknown
25
Not yet recruiting
9
Recruiting
8
Withdrawn
2
Terminated
1

Phase

Phase 3
10
Phase 2
6
Phase 4
1

Where

Egypt
35
Turkey
8
France
4
Pakistan
3
China
3
Korea, Republic of
2

Who runs them

Assiut University (13) · Aswan University Hospital (9) · Cairo University (7) · Ain Shams University (5) · Seoul National University Bundang Hospital (2) · Sohag University (2) · University Hospital, Angers (1) · Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital (1)

What is being tested here

Drugs under test in Placenta Previa studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tranexamic Acid3510
Arginine Vasopressin111
Sodium Chloride111
Epinephrine101
17 alpha-Hydroxyprogesterone Caproate002
Progesterone002
Misoprostol001
Magnesium Sulfate011
Nifedipine001

Drug classes tested here Progestins 3

Coming up

2phase 3 studies under way
7studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7, phase 3 first

Who these studies take

Of the 8 Placenta Previa studies recruiting now, 4 (50%) set no upper age limit and 4 (50%) stop at 75 or younger. 1 (13%) take children under 18. 8 (100%) are for women only and 0 (0%) for men only; 4 (50%) take healthy volunteers.

Recruiting studies that take each age, of 8
AgeWomenMen
101 (13%)0 (0%)
188 (100%)0 (0%)
308 (100%)0 (0%)
408 (100%)0 (0%)
505 (63%)0 (0%)
655 (63%)0 (0%)
754 (50%)0 (0%)
854 (50%)0 (0%)

Across all 80 studies, recruiting or not: 73% stop at 75 or younger and 73% at 65; 24% take children; 99% are for women only and 0% for men only; 35% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Placenta Previa studies take

Of 23 interventional studies with no phase under Placenta Previa, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase14 mo10–36 · 23 studies——
Observational18 mo5–36 · 15 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 80. Browse all 80 → or search them.